NTRK Fusion Gene Positive Advanced Solid Tumors Strategic Business Report 2024, with Coverage of Major Players such as Amoy Diagnostics, AnHeart Therapeutics, ARUP Laboratories, EntroGen and More
17. September 2024 08:00 ET
|
Research and Markets
Dublin, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The "NTRK Fusion Gene Positive Advanced Solid Tumors - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global...